It was found that 3-5% of first pregnancies and 1% of subsequent pregnancies are complicated by preeclampsia. 1 WHO estimated that approximately 60,000 women die each year from pre-eclampsia world-wide. Pre-eclampsia and eclampsia account for 24% of all ABSTRACT Background: Pre-eclampsia accounts for the majority of referrals in a tertiary care centre as it stands one of the major causes of maternal and perinatal morbidity and mortality. The objective of this study was to study the maternal and fetal outcome in patients with severe pre-eclampsia and eclampsia in a tertiary centre over a period of one year. Methods: Total 150 women with severe eclampsia and eclampsia after 20 weeks of gestation were included. Women with medical complications like anemia, preexisting hypertension, epilepsy, diabetes, vascular or renal disease, multiple gestation, polyhydramnios were excluded. Patients were managed as per existing protocol after proper history, examination and investigations. Anti-hypertensive of choice was alphamethyl-dopa, labetalol and oral nefidipene. Magnesium sulphate was used as anti convulsant. Results: Out of 150 cases of severe pre-eclampsia and eclampsia, majority (69%) were between 20-30 years of age and 47% were primigravida. We had 75 patients with convulsions on admission and 75 with severe pre-eclampsia of whom 11 had convulsions. Headache was most common complaint. Common mode of delivery was caesarean section in 72 (48%) women, majority in view of failed induction or non-progress. Maternal complications were noted in 59% attributed to renal dysfunction, postpartum hemorrhage, DIC, placental abruption, HELLP, pulmonary edema, pulmonary embolism and renal failure. 4 maternal deaths were recorded. Conclusions: Maternal and perinatal complications are more in patients with eclampsia. The incidence of eclampsia can be reduced by better antenatal care, early recognition and prompt treatment of severe pre-eclampsia.
INTRODUCTION
Hypertension in pregnancy constitutes the most common medical complication occurring in 12-22% of all pregnancies of which pre-eclampsia remains the leading cause that complicates 10% of all pregnancies. 1, 2 It is defined as new onset of elevated blood pressure and proteinuria (BP>/=140/90 and >/= 0.3gm protein in 24 hours urine specimen) after 20 weeks of gestation in a previously normotensive woman. 3, 4 It is considered severe if blood pressure and proteinuria are increased substantially (BP>/=160/110 and >5 gm protein in 24 hours urine specimen) or symptoms of end organ damage like thrombocytopenia, altered liver function, oliguria, cerebral or visual disturbances, pulmonary edema and fetal growth restriction are present. 3, 4 Eclampsia is defined as the new onset of generalized tonic clonic seizure in a woman with severe preeclampsia. Seizures most commonly occur in the postnatal period in 44% cases, antenatally in 38% and in the intrapartum period in 18%. 5 maternal deaths in India, mainly attributed to complications like accidental haemorrhage, disseminated intravascular coagulation, pulmonary edema, cardiac failure, HELLP syndrome, renal failure, adult respiratory distress syndrome and cerebral hemorrhage. 6 Preeclampsia is a multisystem disorder where release of one or more factors damage the vascular endothelial cells throughout the maternal circulation leading to multisystem dysfunction. 7 There is currently no single cost effective and reliable screening test for preeclampsia and there are no well-established measures for primary prevention.
The ultimate treatment for pre-eclampsia to prevent potential maternal complications is to deliver the patient. However, delivery is not always in best interest of fetus. The rationale for delaying delivery in these pregnancies, is to reduce perinatal morbidity and mortality by delivery of more mature fetus and to lesser degree to achieve more favourable cervix. [8] [9] [10] Access to perinatal care, early detection of the disorder, careful monitoring and appropriate management are crucial elements in prevention of pre-eclampsia related deaths. Pre-eclampsia is associated with increased risk of disseminated intravascular coagulation, placental abruption, hepatic failure, acute renal failure, cerebrovascular and cardiovascular complications, pulmonary edema, HELLP syndrome, eclampsia, retinal detachment, aspiration pneumonia and maternal death. Fetal morbidities include preterm delivery, small for gestation, intrauterine growth restriction (IUGR), still births, low birth weight babies. 6, 11 The term "eclampsia" is derived from a Greek word meaning "like a flash of lightening". Alexander Hamilton (1781) described eclampsia as a disease which always attended with the utmost hazard and frequently kills the woman like a fit of apoplexy. Eclampsia; a complication of preeclampsia is a life threatening emergency that continues to be a major cause of maternal and perinatal morbity and mortality worldwide. According to Doeley's estimation, globally about 50,000 women die of eclampsia annually. Majority of these deaths occur in developing countries and most of these are preventable. 12 In India, maternal mortality and morbidity from eclampsia is very high. The figure ranges from 8-14%. The perinatal mortality ranges from 14.6% to 47.4%. 13, 14 The incidence of eclampsia can be reduced by better antenatal care, early recognition and prompt treatment of severe pre-eclampsia. 15, 16 For ignorant or undiagnosed patients who present with convulsions, we can offer emergency services which will definitely help to reduce both maternal and perinatal mortality due to eclampsia. The clinical management of eclampsia has gone through many changes and achieved good results with the introduction of various treatment regimes. 16 Ours being a tertiary care centre, receives many complicated cases as emergency from peripheral, maternity clinics and nursing homes. The present study is undertaken to find out maternal and perinatal mortality and morbidity rate in severe pre-eclampsia and eclampsia; also to identify the factors influencing maternal and perinatal outcome.
METHODS
The present study is prospective study carried out on 150 pregnant women of severe pre-eclampsia and eclampsia with more than 20 weeks of gestation who were admitted from 1 st January 2014 to 31 st December 2014 in our tertiary centre. Patients with medical complications like anaemia, preexisting hypertensive, diabetes, vascular or renal disease, multiple gestation, polyhydramnios, GTN were excluded from the study. The outcome of each pregnancy was obtained by examining the patient in labour ward and neonates in neonatal intensive care unit.
On admission detailed demographic, personal, medical, obstetric and family history was recorded from the patient or her attendant as appropriate. General physical examination, systemic, abdominal and pelvic examinations were carried out. Investigations like complete blood count with absolute platelet count, liver function tests, renal function tests, coagulation profile, and fundoscopy and urine examination were performed for all patients. Ultrasound was done at the time of admission after patient stabilization. Obstetric management was carried out as per department protocol. Corticosteroids were administered if gestational age was less than 34 weeks gestation. The decision regarding timing and mode of delivery were individualized. Eclamptic patients were given magnesium sulphate by Pritchard's regimen; anti-hypertensive drugs were nifedipine, methyldopa, and labetalol singly or in combination. Obstetric management was done (spontaneous/ induced labor) as per the unit protocols and patients were delivered either by vaginal route or by cesarean section. Neonatal care was provided by pediatrician from delivery onwards. The patients with uncontrolled hypertension were managed in collaboration with physician and anesthetist.
All the mothers were followed up for evidence of change in BP and to look for other complications of eclampsia for 6 weeks. All the babies delivered were followed up during early neonatal period for complications. Maternal and perinatal complications were noted down. At the end of the study, the data was compiled and analyzed. We had 104 (69%) patients between 20-30 years of age followed by 16% patients beyond 35 years of age. More than half of the patients in our study (59%) were unbooked/transferred. Majority patients (64%) presented before 37 completed weeks of gestation, followed by those presenting up to 40 weeks of gestation. The mode of delivery in these patients was determined on the basis of fetal condition, gestational age and bishops score. Labor induction was done after assessing the above factors. Our study showed that LSCS was performed in majority patients (42.3%) in view of failed induction or non-progress. However, 37% patients delivered vaginally. Most common indication for operative intervention was failed induction or non-progress followed by fetal distress in our study. 45 patients with eclampsia delivered between 13-24 hours after first convulsion. However, 23 patients delivered within 6-12 hours of the first convulsion.
RESULTS

Out
One patient expired antenatally due to acute kidney injury and HELLP. Neonatal deaths were mostly due to extreme prematurity and its complications. Thus it is evident from the above table that patients of eclampsia had more complications as compared to severe pre-eclampsia.
There was poor perinatal outcome in both the groups; that is perinatal loss was seen in 30% of the cases.
DISCUSSION
During the study period, there were 27,755 obstetric admissions including 150 cases of severe pre-eclampsia and eclampsia.
Out of 150 patients, 75 patients were referred from other institutions with convulsions for appropriate obstetric management. We report headache as the main symptom in 66 patients of severe pre-eclampsia. However, 11 patients of severe pre-eclampsia later on developed convulsions (8 were antepartum and 3 were postpartum), followed by edema feet, vomiting, blurring of vision oliguria and epigastric pain in the rest.
A study done by Singhal SR et al showed that 44% patients in their study had headache as the main symptom. 17 In our study, we report convulsions in 83 patients. However, similar study done by Singhal SR et al showed that 51% of patients had presented with convulsions. 17 More than half of the patients in our study (59%) were unbooked/transferred, a finding that correlates with the study done by Shaikh S et al who had 82% patients unbooked/transferred. 18 Saxena N et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jul;5 (7) :2171-2176
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Most of the patients 104 (69%) were falling in the age group between 20-30 years. Similar findings were obtained from reports of Nishtar hospital Multan. 19 Also study done by Singhal SR et al showed that 90% patients were less than 30 years of age. 17 It was found that 46.6% patients were primigravidas. There was increased incidence of operative delivery (48%) in these patients. The mode of delivery in these patients was determined on the basis of fetal condition, gestational age and bishops score. Labor induction was done after assessing the above factors. A study by Shaikh S et al showed caesarean rate of 73% and vaginal delivery in 26.7%. One patient died antenatally due to HELLP with acute kidney injury.
Most common indication for operative intervention was failed induction or non-progress followed by fetal distress in our study where as it was uncontrolled blood pressure and fetal distress in the study by Shaikh S et al. Thus patients of eclampsia had more dreadful complications as compared to severe pre-eclampsia. These findings are in good agreement with observations by study done by Singhal SR et al.
CONCLUSION
Pre-eclampsia and eclampsia still remains a major problem in developing countries. It is one of the important causes of maternal and perinatal morbidity and mortality probably resulting from inadequate and suboptimal antenatal care and lack of education and awareness amongst people belonging to low socioeconomic status. Both maternal and perinatal mortality rate are still disappointing. One maternal death occurs in every 25 ecliptic women. This situation demands extension of medical services in rural areas for the benefit of both mother and the baby.
Good antenatal care will identify preeclampsia in early stages.
A moderate reduction of death of mother and fetus in our institution was possible due to wider use of magnesium sulphate, timed delivery, and proper implementation of emergency obstetric care facilities to mother with eclampsia.
The incidence of eclampsia can be reduced by better antenatal care, early recognition and prompt treatment of severe pre-eclampsia.
For ignorant or undiagnosed patients who present with convulsions, we can offer emergency services which will definitely help to reduce both maternal and perinatal mortality due to eclampsia.
Adequate assessment, investigation, monitoring and intensive care for these women in the antepartum, intrapartum and postpartum period and timely delivery improve significantly the maternal and perinatal outcome. Regular blood pressure monitoring specially in predisposed individuals is essential to detect such high cases early and thus prevent complications. This can be done with the help of family physicians.
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